Literature DB >> 1184732

Production of influenza virus complement-fixing antibody in mouse ascitic fluid.

L A White, W C Gamble, W A Chappell.   

Abstract

Suspension cultures of BHK-21/13s cells infected with either A/Hong Kong/8/68 or B/Massachusetts/3/66 strains of influenza were used to prepare type-specific influenza ribonucleoprotein-immunizing antigens. These antigens were used in comparing four immunization schedules in the production of immune mouse ascitic fluids. Large volumes of ascitic fluids were obtained by these schedules. These fluids contained type-specific complement-fixing antibody and were devoid of nonspecific host tissue or heterologous cross-reactions.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1184732      PMCID： PMC362796          DOI： 10.1128/jcm.2.4.287-291.1975

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  CHARACTERIZATION OF "SOLUBLE" ANTIGENS DERIVED FROM CELLS INFECTED WITH SENDAI AND NEWCASTLE DISEASE VIRUSES.

Authors:  R ROTT; A P WATERSON; I M REDA
Journal:  Virology       Date:  1963-12       Impact factor: 3.616

2.  ENTEROVIRUS ANTIBODIES IN MOUSE ASCITIC FLUIDS AFTER IMMUNIZATION.

Authors:  A FABIYI; H A WENNER
Journal:  J Immunol       Date:  1965-02       Impact factor: 5.422

3.  A simple rapid method for production of viral antibody in mice.

Authors:  S BERKOVICH
Journal:  Proc Soc Exp Biol Med       Date:  1962-10

4.  Method of concentration of viral diagnostic reagents using hydrophilic agents.

Authors:  M A BUCCA; H L CASEY; J F WINN
Journal:  Proc Soc Exp Biol Med       Date:  1960-06

5.  Tumor cell-induced mouse ascites fluid as a source of viral antibodies.

Authors:  E C HERRMANN; C ENGLE
Journal:  Proc Soc Exp Biol Med       Date:  1958-06

6.  Production and characterization of arbovirus antibody in mouse ascitic fluid.

Authors:  W E Brandt; E L Buescher; F M Hetrick
Journal:  Am J Trop Med Hyg       Date:  1967-05       Impact factor: 2.345

7.  Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation.

Authors:  J C Hierholzer; M T Suggs; E C Hall
Journal:  Appl Microbiol       Date:  1969-11

8.  Use of sarcoma 180/TG to prepare hyperimmune ascitic fluid in the mouse.

Authors:  A C Sartorelli; D S Fischer; W G Downs
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

9.  Properties of the Hong Kong influenza virus. I. General characteristics of the Hong Kong virus.

Authors:  M T Coleman; W R Dowdle
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

10.  Comparison of immunization methods for producing reference adenovirus antisera in horses.

Authors:  J C Hierholzer; W C Gamble; K D Quist; W A Chappell
Journal:  Appl Microbiol       Date:  1972-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.